This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s ...

The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...

Auvi-Q (epinephrine) is a brand-name injectable drug. It’s prescribed for emergency treatment of severe allergic reactions. Auvi-Q has interactions with some other drugs, including diuretics and ...

HERSHEY, Pa. — Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United Stated topped $722 billion, a trend that’s expected to continue. Yet, ...

A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and strokes – something no existing treatment has been able to do. Despite a significant ...

Auvi-Q (epinephrine) is a prescription drug used to treat severe allergic reactions. Auvi-Q’s cost may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you ...

Please provide your email address to receive an email when new articles are posted on . Some obesity drugs in development have different mechanisms of action and may cost less than currently available ...

Specialty drugs, especially biologics, will constitute a significant portion of global drug spending by 2029, driven by cancer care costs. Autoimmune diseases and multiple sclerosis are key short-term ...